TATVA CHINTAN PHARMA CHEM
Back to Balance Sheet
|
TATVA CHINTAN PHARMA CHEM Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹87 Cr | ₹241 Cr | ₹171 Cr | ₹128 Cr | ₹88 Cr |
What is the latest Total Current Liabilities ratio of TATVA CHINTAN PHARMA CHEM ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹87 Cr |
Mar2023 | ₹241 Cr |
Mar2022 | ₹171 Cr |
Mar2021 | ₹128 Cr |
Mar2020 | ₹88 Cr |
How is Total Current Liabilities of TATVA CHINTAN PHARMA CHEM Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹87 Cr | -63.83 | |
Mar2023 | ₹241 Cr | 40.52 | |
Mar2022 | ₹171 Cr | 33.32 | |
Mar2021 | ₹128 Cr | 46.50 | |
Mar2020 | ₹88 Cr | - |
Compare Total Current Liabilities of peers of TATVA CHINTAN PHARMA CHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TATVA CHINTAN PHARMA CHEM | ₹1,759.4 Cr | -2.5% | -11.8% | -40.8% | Stock Analytics | |
PIDILITE INDUSTRIES | ₹146,014.0 Cr | -3% | -1.1% | 7.8% | Stock Analytics | |
SRF | ₹85,414.8 Cr | -2.1% | 10.7% | 26.1% | Stock Analytics | |
SOLAR INDUSTRIES INDIA | ₹82,156.4 Cr | -4.5% | -4.7% | 32.1% | Stock Analytics | |
GUJARAT FLUOROCHEMICALS | ₹40,658.8 Cr | 2.5% | -2.4% | 2.6% | Stock Analytics | |
DEEPAK NITRITE | ₹32,104.2 Cr | 1% | -2.8% | 6.7% | Stock Analytics |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TATVA CHINTAN PHARMA CHEM | -2.5% |
-11.8% |
-40.8% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses